Thomas Kaley

MathematicsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Papers

Driven by 21 papers — median percentile 0. Top paper: “Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors”.

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005147

N/A

1.7DataRank · unranked

66 citations

Michael J. Pishvaian, Margaret K. Callahan, Amy Weise, Branimir I. Šikić, Osama E. Rahma +19 more

Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases

npj Breast Cancer(2022)10.1038/s41523-022-00404-2

N/A

0.996DataRank · unranked

31 citations

Kathryn Beal, Stefanie N. Linch, Kateri J. Spinelli, Micaela Rodine, Darragh Halpenny +12 more

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2502

N/A

0.964DataRank · unranked

24 citations

Erin Twohy, Elizabeth R. Gerstner, Timothy J. Kaufmann, A. John Iafrate, Suriya Jeyapalan +16 more

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2500

N/A

0.835DataRank · unranked

261 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2223734

N/A

0.431DataRank · unranked

9 citations

Elena Pentsova, Lauren Schaff, Craig Nolan, Thomas Kaley, Anne S. Reiner +3 more

Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4064

N/A

0DataRank · unranked

44 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395.v1

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168.v1

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0605

N/A

0DataRank · unranked

25 citations

Subhiksha Nandakumar, Lauren Schaff, Igor T. Gavrilovic, Thomas Kaley, Craig Nolan +21 more

Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01846-4

N/A

0DataRank · unranked

20 citations

Alexandra Miller, Bridget M Holle, Justin Jee, Siyang Liu, Dara S. Ross +27 more

Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors

The Journal of Clinical Endocrinology & Metabolism(2025)10.1210/clinem/dgaf178

N/A

0DataRank · unranked

10 citations

Vasilisa A. Rudneva, Adam Newton, Nazanin Majd, Rajiv Magge, Soma Sengupta +12 more

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors

Acta Neuropathologica(2025)10.1007/s00401-025-02935-x

N/A

0DataRank · unranked

2 citations

Miika Mehine, Yelena Kemel, Chaitanya Bandlamudi, Diana Mandelker, Marc K. Rosenblum +36 more

Symptomatic Prostate-Specific Membrane Antigen PET–Positive Radionecrosis After Multimodality Brain Metastasis–Directed Treatment Including [177Lu]Lu-PSMA-617

Journal of Nuclear Medicine(2025)10.2967/jnumed.124.269175

N/A

0DataRank · unranked

1 citations

Kenny Yu, Wassim Abida, Luke Pike, Milan Grkovski, Thomas Kaley +10 more

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network(2020)10.6004/jnccn.2020.0052

N/A

0DataRank · unranked

570 citations

Jana Portnow, Manmeet S. Ahluwalia, Joachim M. Baehring, Henry Brem, Steven Brem +30 more

Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment

Neuro-Oncology Practice(2025)10.1093/nop/npaf109

N/A

0DataRank · unranked

0 citations

Anne S. Reiner, William E. Rosa, Brandon S. Imber, Luke Pike, Louis Voigt +12 more

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51009

N/A

0DataRank · unranked

46 citations

Katherine S. Panageas, Elena Pentsova, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic +8 more

Value of [18F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa050

N/A

0DataRank · unranked

6 citations

Simone Krebs, Tejus Bale, Kwaku Domfe, Stephanie Lobaugh, Zhigang Zhang +4 more

Intratumoral drug distribution of adavosertib in patients with glioblastoma: Interim results of phase I study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2568

N/A

0DataRank · unranked

6 citations

Brian M. Alexander, Nathalie Y.R. Agar, Manmeet S. Ahluwalia, Arati Desai, Jörg Dietrich +14 more

EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors

Neuro-Oncology(2022)10.1093/neuonc/noac188

N/A

0DataRank · unranked

70 citations

David Capper, Adam Waldman, Johan Pallud, Giuseppe Minniti, Thomas Kaley +15 more

Thomas Kaley

Indexed papers

Top data-sharing exemplar

Papers